title: Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
authors.forename: Louise
authors.initials: L
authors.lastname: Kuhn
authors.forename: Moses
authors.initials: M
authors.lastname: Sinkala
authors.forename: M P H Chipepo
authors.initials: MP
authors.lastname: Kankasa
authors.forename: Prisca
authors.initials: P
authors.lastname: Kasonde
authors.forename: Donald M
authors.initials: DM
authors.lastname: Thea
authors.forename: Grace M
authors.initials: GM
authors.lastname: Aldrovandi
mesh_terms: D019943:Amino Acid Substitution; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D024882:Drug Resistance, Viral / Q000235:genetics*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission* / Q000821:virology; D054303:HIV Reverse Transcriptase / Q000235:genetics; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D009154:Mutation; D019829:Nevirapine / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000821:virology
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine; D054303:HIV Reverse Transcriptase